Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• ABT scores best on the Stability dimension, with a Stability rank ahead of 89.02% of US stocks.
• ABT's strongest trending metric is Growth; it's been moving down over the last 177 days.
• ABT ranks lowest in Growth; there it ranks in the 16th percentile.

ABT Stock Summary

• ABBOTT LABORATORIES's market capitalization of $193,100,795,803 is ahead of 99.14% of US-listed equities.
• ABBOTT LABORATORIES's stock had its IPO on January 1, 1986, making it an older stock than 93.46% of US equities in our set.
• In terms of volatility of its share price, ABT is more volatile than only 3.11% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to ABBOTT LABORATORIES, a group of peers worth examining would be DHR, TMO, SHEL, DIS, and AZN.
• ABT's SEC filings can be seen here. And to visit ABBOTT LABORATORIES's official web site, go to www.abbott.com.

ABT Valuation Summary

• In comparison to the median Healthcare stock, ABT's EV/EBIT ratio is 98.03% higher, now standing at 20.1.
• ABT's price/sales ratio has moved up 1 over the prior 243 months.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

The 5 year net cashflow from operations growth rate now stands at 91.66%.
• The 2 year cash and equivalents growth rate now stands at 127.27%.
• Its 4 year revenue growth rate is now at 53.91%.

Over the past 15 months, ABT's revenue has gone up $4,797,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	45,030	10,322	7,889
2022-06-30	45,548	10,243	8,554
2022-03-31	44,514	9,961	7,725
2021-12-31	43,075	10,533	7,071
2021-09-30	42,308	11,264	7,244
2021-06-30	40,233	10,629	6,376

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.